|
Session 161
Poster Abstracts
Noninvasive Assessment of Liver Damage
Wednesday, 1 - 4 pm
Poster Hall |
| 908 |
Genomics- and Proteomics-based Approach to Develop Novel Serum Markers in HIV/HCV-co-infected Individuals
Daniel Suzman*1, M McLaughlin1, D Kliener2, A Suffredini3, S Kern3, K Reitano1, D Gonzales3, R Lempicki4, M Polis1, and S Kottilil1
1Lab of Immunoregulation, NIAID, NIH, Bethesda, MD, US; 2NCI, NIH, Bethesda, MD, US; 3NIH, Bethesda, MD, US; and 4SAIC-Frederick/NCI-Frederick, MD, US |
| 909 |
Independent Assessment of Non-invasive Liver Fibrosis Biomarkers in HIV/HCV-co-infected Patients: The Fibrovic Study-ANRS HC 02 RIBAVIC
Patrice Cacoub*1, F Carrat2, P Bedossa3, J Lambert2, G Penaranda4, C Perronne5, S Pol6, P Halfon7, and ANRS HC 02 RIBAVIC
1Hosp Pitie-Salpetriere, Paris, France; 2Univ Paris 6, GHU-Est, France; 3Hosp Beaujon, Clichy, France; 4CDL Pharma, Marseille, France; 5Hosp Raymond Poincare, Garches, France; 6Hosp Necker, Paris, France; and 7Lab Alphabio, Marseille, France |
| 910 |
Failure of Transient Elastometry (Fibroscan) to Differentiate Mild from Significant Liver Fibrosis in HIV/HCV-co-infected Patients
Salvador Vergara*1, J Macías1, A Rivero2, L López-Cortés3, J García-García1, D Merino4, M González5, M Rios-Villegas6, J de la Torre2, and J Pineda1
1Hosp de Valme, Seville, Spain; 2Hosp Reina Sofia, Cordoba, Spain; 3Hosp Virgen del Rocio, Seville, Spain; 4Hosp Juan Ramon Jimenez, Huelva, Spain; 5Hosp Virgen de la Victoria, Malaga, Spain; and 6Hosp Virgen Macarena, Seville, Spain |
| 911 |
Prospective Comparison of Transient Elastography and Liver Biopsy for the Assessment of Fibrosis in Patients with HIV/HBV Co-infection
Patrick Miailhes*1, G Perrot1, F Bailly1, M Chevallier2, L Cotte1, P Pradat1, A Boibieux3, and C Trepo1
1Hotel-Dieu, Lyon, France; 2Lab Marcel Merieux, Lyon, France; and 3Croix-Rousse Hosp, Lyon, France |
912
 |
Biological Non-invasive Tests for Prediction of Liver Fibrosis in HIV-infected Patients with Chronic Hepatitis C: ANRS CO3 Aquitaine Cohort
M A Loko1, L Castera2, F Dabis1,3, F Dabis1,3, B Le Bail4, M Winnock1, G Coureau1, Didier Neau*5, and Groupe d’Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
1INSERM U593, Univ Victor Segalen, Bordeaux, France; 2Ctr Hosp Univ St Andre and Hosp Haut-Leveque, Bordeaux, France; 3CISIH, Ctr Hosp Univ Pellegrin, Bordeaux, France; 4Univ Victor Segalen, Hosp Pellegrin, Bordeaux, France; and 5Ctr Hosp Univ Pellegrin, Bordeaux, France |
913
|
Biochemical Scores for Liver Fibrosis in HIV/HBV-co-infected Patients: Accuracy in Detecting Cirrhosis but Not Mild or Bridging Fibrosis
Karine Lacombe*1,2, Karine Lacombe*1,2, V Massari2, J Guéchôt1, D Wendum1, M Chevallier3, P Callard4, L Serfaty1, G Pialoux4, J M Molina5, and P M Girard1
1Hosp St Antoine, Paris, France; 2INSERM U707, Univ Pierre and Marie Curie, Paris, France; 3Hotel-Dieu, Lyon, France; 4Hosp Tenon, Paris, France; and 5Hosp St Louis, Paris, France |
914
|
Improving Non-invasive Discrimination of Fibrosis Stage in HIV/HCV-co-infected Patients
Norah Shire*1, M Rao1, J Andersen2, A Butt3, R Chung4, K Sherman1, and The ACTG 5178 Study Group
1Univ of Cincinnati, OH, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of Pittsburgh, PA, US; and 4Massachusetts Gen Hosp, Boston, US |
915
|
Soluble TNF Receptor II Levels Are Elevated in HCV/HIV Co-infection and Are Associated with Advanced Liver Fibrosis Stage
Margaret Shuhart*, M Chung, D Paschal, M Wener, D Gretch, and C Morishima
Univ of Washington, Seattle, US |
916
|
Markers of Liver Fibrosis Predict Adverse Liver Outcomes in a Population of HCV+ Individuals with and without HIV Co-infection
D Nunes1,2, D Nunes1,2, G Offner1, K Chambers1, C Reed3, T Heeren3, S Tumilty2, S Stuver3, C Graham4,5, C Graham4,5, C Horsburgh1,2,3, C Horsburgh1,2,3, C Horsburgh1,2,3, Deborah Cotton*1,2,3, Deborah Cotton*1,2,3, Deborah Cotton*1,2,3, and Hepatitis C, HIV And Related Morbidity (CHARM)
1Boston Univ Sch of Med, MA, US; 2Boston Med Ctr, MA, US; 3Boston Univ Sch of Publ Hlth, MA, US; 4Beth Israel Deaconess Med Ctr, Boston, MA, US; and 5Harvard Med Sch, Boston, MA, US |
| 917 |
Insulin Resistance and Progression to Liver Fibrosis in HIV/HCV-co-infected Patients Participating to the Prospective ANRS Co13 French Cohort Study
Dominique Salmon*1, M A Loko2, S Dominguez3, P Bonnard4, P Morlat5, L Merchadou2, P Sogni1, L Alric6, F Dabis2, and Y Benhamou3
1Hosp Cochin, Paris, France; 2INSERM U593, Univ Victor Segalen, Bordeaux, France; 3Hosp Pitie Salpetriere, Paris, France; 4Hosp Tenon, Paris, France; 5Hosp St-Andre, Bordeaux, France; and 6Hosp Purpan, Toulouse, France |
918
|
Low Prevalence of Moderate-severe Liver Fibrosis Assessed by Transient Hepatic Elastography in HIV-infected Patients without HBV or HCV Co-infection
Nicolás Merchante*, E Recio, J Mira, S Vergara, J García-García, J del Valle, J Macías, J Gómez-Mateos, F Lozano, and J Pineda
Hosp Univ de Valme, Seville, Spain |
|
